Feeds
40322 items (40322 unread) in 74 feeds
Acinar Cell Carcinoma
(947 unread)
Acinic Cell Carcinoma
(353 unread)
Adenoid Cystic Carcinoma
(509 unread)
Adrenal Gland Cancer
(3507 unread)
Ampulla Of Vater
(575 unread)
Anal Cancer
(3208 unread)
Angiosarcoma
(1004 unread)
Appendix Cancer
(1264 unread)
Bile Duct Cancer
(5441 unread)
Brain and CNS
(7735 unread)
Carcinoid
(859 unread)
Endocrine/Neuroendocrine
(6661 unread)
Gall Bladder Cancer
(1824 unread)
Hemangioendothelioma
(1750 unread)
Hepatoblastoma
(545 unread)
Pancreas
(607 unread)
Phyllodes
(491 unread)
PMP and Mucinous Tumors
(396 unread)
Rhabdomyosarcoma
(1282 unread)
Sarcoma
(1364 unread)
Google - Neuroendocrine Tumor (100 unread)
-
Niraparib by GSK for Esophageal Cancer: Likelihood of Approval - Pharmaceutical Technology
Posted: December 5th, 2023, 2:31am GMT
Niraparib by GSK for Esophageal Cancer: Likelihood of Approval Pharmaceutical Technology -
Acrixolimab by Y-Biologics for Recurrent Head And Neck Squamous ... - Pharmaceutical Technology
Posted: December 5th, 2023, 1:31am GMT
Acrixolimab by Y-Biologics for Recurrent Head And Neck Squamous ... Pharmaceutical Technology -
Acrixolimab by Y-Biologics for Penile Cancer: Likelihood of Approval - Pharmaceutical Technology
Posted: December 5th, 2023, 1:31am GMT
Acrixolimab by Y-Biologics for Penile Cancer: Likelihood of Approval Pharmaceutical Technology -
Dr Bestvina on the Management of AEs Associated With ... - OncLive
Posted: December 5th, 2023, 11:25pm GMT
-
Antidepressant Use Lowers Mortality Risk in HCC - Targeted Oncology
Posted: December 4th, 2023, 9:00pm GMT
Antidepressant Use Lowers Mortality Risk in HCC Targeted Oncology -
BDTX-1535 Strives to Overcome Intrinsic and Acquired EGFR ... - OncLive
Posted: December 4th, 2023, 6:34pm GMT
-
Carotid Body Tumor in a 26-Year-Old Male Patient Managed With ... - Cureus
Posted: December 4th, 2023, 4:06pm GMT
-
Ipilimumab by Bristol-Myers Squibb for Merkel Cell Carcinoma ... - Pharmaceutical Technology
Posted: December 4th, 2023, 3:04pm GMT
Ipilimumab by Bristol-Myers Squibb for Merkel Cell Carcinoma ... Pharmaceutical Technology -
Deep Learning Platform for Quantification of Ki-67 in Tumors | IJGM - Dove Medical Press
Posted: December 4th, 2023, 7:48am GMT
Deep Learning Platform for Quantification of Ki-67 in Tumors | IJGM Dove Medical Press -
NBC Correspondent Antonia Hylton Reveals Rare Cancer Diagnosis - BET
Posted: December 1st, 2023, 1:59pm GMT
-
NBC News Correspondent Antonia Hylton Shares Details Of Her ... - Deadline
Posted: December 1st, 2023, 12:47am GMT
-
NBC's Antonia Hylton Diagnosed with Rare Cancer - PEOPLE
Posted: November 30th, 2023, 5:58pm GMT
-
Skin Malignancies: Imaging Review with Radiologic-Histopathologic ... - RSNA Publications Online
Posted: November 30th, 2023, 4:19pm GMT
Skin Malignancies: Imaging Review with Radiologic-Histopathologic ... RSNA Publications Online -
Is it a Good Idea to Invest in Harpoon (HARP) Stock Now? - Nasdaq
Posted: November 30th, 2023, 2:07pm GMT
-
Is it a Good Idea to Invest in Harpoon (HARP) Stock Now? - Yahoo Finance
Posted: November 30th, 2023, 2:07pm GMT
Is it a Good Idea to Invest in Harpoon (HARP) Stock Now? Yahoo Finance -
NBC News' Antonia Hylton Reveals Symptoms of Rare Cancer - TODAY
Posted: November 30th, 2023, 1:35pm GMT
-
Comprehensive analysis of necroptotic patterns and associated ... - Nature.com
Posted: November 30th, 2023, 4:37am GMT
-
Uncommon but Not Elusive: A Case of Syringocystadenoma ... - Cureus
Posted: November 30th, 2023, 4:10am GMT
-
Guideline Spotlights Early-Line Agents for GEP-NETs - Targeted Oncology
Posted: November 29th, 2023, 9:00pm GMT
Guideline Spotlights Early-Line Agents for GEP-NETs Targeted Oncology -
UCLA researchers detail how prostate cancers grow more ... - UCLA Health Connect
Posted: November 29th, 2023, 8:48pm GMT
UCLA researchers detail how prostate cancers grow more ... UCLA Health Connect -
BI 764532 Earns FDA FTD in Large Cell Lung Neuroendocrine ... - Cancer Network
Posted: November 29th, 2023, 5:05pm GMT
-
Debating Issues in Frontline Treatment Approach for Advanced HCC - Targeted Oncology
Posted: November 29th, 2023, 5:00pm GMT
Debating Issues in Frontline Treatment Approach for Advanced HCC Targeted Oncology -
Telisotuzumab Vedotin Meets Clinical End Points in LUMINOSITY ... - OncLive
Posted: November 29th, 2023, 3:14pm GMT
-
C1QA and COMP: plasma-based biomarkers for early diagnosis of ... - Nature.com
Posted: November 29th, 2023, 8:17am GMT
-
Sustained Clinical Response to 4th-Line Therapy with Selpercatinib ... - Dove Medical Press
Posted: November 29th, 2023, 6:12am GMT
Sustained Clinical Response to 4th-Line Therapy with Selpercatinib ... Dove Medical Press -
Kymiterese Wicker Obituary (2023) - Syracuse, NY - Syracuse Post ... - Syracuse Post Standard Obituaries
Posted: November 28th, 2023, 9:46pm GMT
Kymiterese Wicker Obituary (2023) - Syracuse, NY - Syracuse Post ... Syracuse Post Standard Obituaries -
December 2023 Issue of Neurosurgical Focus: “Enhanced Recovery ... - Newswise
Posted: November 28th, 2023, 6:05pm GMT
-
Nucleus RadioPharma: Building CDMO Sites to Ride the ... - Genetic Engineering & Biotechnology News
Posted: November 28th, 2023, 4:55pm GMT
Nucleus RadioPharma: Building CDMO Sites to Ride the ... Genetic Engineering & Biotechnology News -
Five biotech companies in Texas shaping the state's hubs - Labiotech.eu
Posted: November 28th, 2023, 12:02pm GMT
-
Terbium-161: New radionuclide for targeted cancer therapy hits ... - Science X
Posted: November 28th, 2023, 9:03am GMT
-
Ramucirumab by Eli Lilly and Co for Metastatic Adenocarcinoma of ... - Pharmaceutical Technology
Posted: November 28th, 2023, 6:12am GMT
Ramucirumab by Eli Lilly and Co for Metastatic Adenocarcinoma of ... Pharmaceutical Technology -
Need for Systemic Therapy Remains in Sarcoma - Targeted Oncology
Posted: November 27th, 2023, 9:00pm GMT
Need for Systemic Therapy Remains in Sarcoma Targeted Oncology -
Sara Cook Obituary - Mueller-Bies Funeral Home - Roseville Chapel ... - Legacy.com
Posted: November 27th, 2023, 6:00am GMT
-
Anesthetic Management of Emergency Insulinoma Resection: Case ... - Cureus
Posted: November 26th, 2023, 10:20am GMT
-
Behind the Development of Ivaltinostat in Metastatic PDAC - Targeted Oncology
Posted: November 26th, 2023, 11:00pm GMT
Behind the Development of Ivaltinostat in Metastatic PDAC Targeted Oncology -
Selection, characterization and in vivo evaluation of novel CD44v6 ... - Nature.com
Posted: November 24th, 2023, 8:28am GMT
-
Delay in diagnosis to treatment and impact on survival of gastric ... - Nature.com
Posted: November 23rd, 2023, 6:37pm GMT
-
DLL3: A Highly Selective Cancer Target | Antibodies | News Channels - PipelineReview.com
Posted: November 23rd, 2023, 3:28pm GMT
DLL3: A Highly Selective Cancer Target | Antibodies | News Channels PipelineReview.com -
Breakthrough AI tool PANDA shows promise in early detection of ... - News-Medical.Net
Posted: November 23rd, 2023, 12:05pm GMT
Breakthrough AI tool PANDA shows promise in early detection of ... News-Medical.Net -
Trueperella pyogenes endocarditis in a Swiss farmer: a case report ... - BMC Infectious Diseases
Posted: November 23rd, 2023, 11:48am GMT
Trueperella pyogenes endocarditis in a Swiss farmer: a case report ... BMC Infectious Diseases -
Nancy Christoff-Hass Obituary - Newcomer Cremations, Funerals ... - Legacy.com
Posted: November 23rd, 2023, 4:00am GMT
-
Resection of the primary tumor improves the prognosis of ... - BMC Gastroenterology
Posted: November 23rd, 2023, 1:46am GMT
Resection of the primary tumor improves the prognosis of ... BMC Gastroenterology -
Behind the FDA Approval of Enzalutamide for Prostate Cancer - Targeted Oncology
Posted: November 23rd, 2023, 11:00pm GMT
Behind the FDA Approval of Enzalutamide for Prostate Cancer Targeted Oncology -
Mahvash Disease Case Resolved With Liver Transplantation - Medpage Today
Posted: November 22nd, 2023, 8:01pm GMT
Mahvash Disease Case Resolved With Liver Transplantation Medpage Today -
FDA Oks FoundationOne®CDx for Capivasertib/Fulvestrant in ... - Targeted Oncology
Posted: November 22nd, 2023, 6:35pm GMT
FDA Oks FoundationOne®CDx for Capivasertib/Fulvestrant in ... Targeted Oncology -
MRT-2359 Shows Favorable Tolerability in Heavily Pretreated MYC ... - OncLive
Posted: November 21st, 2023, 12:38pm GMT
-
The Impact of Irregular Menstruation on Health: A Review of the ... - Cureus
Posted: November 21st, 2023, 3:27am GMT
-
The Impact of Irregular Menstruation on Health: A Review of the ... - Cureus
Posted: November 21st, 2023, 3:27am GMT
-
AI Models in Prostate Cancer Tackle Treatment Disparities Facing ... - Targeted Oncology
Posted: November 20th, 2023, 5:00pm GMT
AI Models in Prostate Cancer Tackle Treatment Disparities Facing ... Targeted Oncology -
Adrenocorticotropin-Dependent Ectopic Cushing's Syndrome: A ... - Cureus
Posted: November 20th, 2023, 4:46pm GMT
-
Risks and benefits of TIPS in HCC and other liver malignancies: a ... - BMC Gastroenterology
Posted: November 20th, 2023, 1:21pm GMT
Risks and benefits of TIPS in HCC and other liver malignancies: a ... BMC Gastroenterology -
Global Peptide Receptor Radionuclide Therapy (PRRT) Industry ... - PharmiWeb.com
Posted: November 20th, 2023, 10:33am GMT
-
Nancy M. Christoff-Hass Obituary - Green Bay Press Gazette
Posted: November 20th, 2023, 6:00am GMT
Nancy M. Christoff-Hass Obituary Green Bay Press Gazette -
Toripalimab by Shanghai Junshi Biosciences for Ureter Cancer ... - Pharmaceutical Technology
Posted: November 19th, 2023, 11:58pm GMT
Toripalimab by Shanghai Junshi Biosciences for Ureter Cancer ... Pharmaceutical Technology -
Berzosertib by Merck for Solid Tumor: Likelihood of Approval - Pharmaceutical Technology
Posted: November 18th, 2023, 3:43pm GMT
Berzosertib by Merck for Solid Tumor: Likelihood of Approval Pharmaceutical Technology -
Alpelisib by Novartis for Metastatic Breast Cancer: Likelihood of ... - Pharmaceutical Technology
Posted: November 18th, 2023, 3:38pm GMT
Alpelisib by Novartis for Metastatic Breast Cancer: Likelihood of ... Pharmaceutical Technology -
Penpulimab by Akeso for Nasopharyngeal Cancer: Likelihood of ... - Pharmaceutical Technology
Posted: November 18th, 2023, 1:11am GMT
Penpulimab by Akeso for Nasopharyngeal Cancer: Likelihood of ... Pharmaceutical Technology -
Dosing Complete in First Phase of Trial Evaluating [212Pb]VMT-α ... - Targeted Oncology
Posted: November 17th, 2023, 9:00pm GMT
Dosing Complete in First Phase of Trial Evaluating [212Pb]VMT-α ... Targeted Oncology -
KB-0742 Exhibits Tolerable Safety and Activity in Relapsed ... - OncLive
Posted: November 17th, 2023, 8:00pm GMT
-
Novel Cellular Therapies Aim to Address Off-Tumor, On-Target ... - OncLive
Posted: November 17th, 2023, 6:40pm GMT
-
Role of colectomy in the management of appendiceal tumors: a ... - BMC Gastroenterology
Posted: November 17th, 2023, 6:37am GMT
Role of colectomy in the management of appendiceal tumors: a ... BMC Gastroenterology -
Gradishar Discusses Role of Elacestrant in ER+/HER2– Breast Cancer - Targeted Oncology
Posted: November 17th, 2023, 6:00am GMT
Gradishar Discusses Role of Elacestrant in ER+/HER2– Breast Cancer Targeted Oncology -
Toripalimab by Shanghai Junshi Biosciences for Neuroendocrine ... - Pharmaceutical Technology
Posted: November 17th, 2023, 2:31am GMT
Toripalimab by Shanghai Junshi Biosciences for Neuroendocrine ... Pharmaceutical Technology -
Camrelizumab by Jiangsu Hengrui Medicine for Nasopharyngeal ... - Pharmaceutical Technology
Posted: November 17th, 2023, 2:20am GMT
Camrelizumab by Jiangsu Hengrui Medicine for Nasopharyngeal ... Pharmaceutical Technology -
Spartalizumab by Novartis for Nasopharyngeal Cancer: Likelihood ... - Pharmaceutical Technology
Posted: November 17th, 2023, 2:16am GMT
Spartalizumab by Novartis for Nasopharyngeal Cancer: Likelihood ... Pharmaceutical Technology -
Avelumab by Merck for Endometrial Cancer: Likelihood of Approval - Pharmaceutical Technology
Posted: November 17th, 2023, 2:06am GMT
Avelumab by Merck for Endometrial Cancer: Likelihood of Approval Pharmaceutical Technology -
Nivolumab by Bristol-Myers Squibb for Nasopharyngeal Cancer ... - Pharmaceutical Technology
Posted: November 17th, 2023, 1:45am GMT
Nivolumab by Bristol-Myers Squibb for Nasopharyngeal Cancer ... Pharmaceutical Technology -
Olaparib With/Without Cediranib Does Not Improve OS Vs Chemo in ... - OncLive
Posted: November 16th, 2023, 6:07pm GMT
-
In Science Journals - Science
Posted: November 16th, 2023, 5:00pm GMT
In Science Journals Science -
Dual-Action Drug Produces Positive Results in Patients With ... - OncLive
Posted: November 16th, 2023, 3:04pm GMT
-
Maria Menounos Suspected ‘Something’s Wrong’ Before Pancreatic Cancer - TODAY
Posted: November 16th, 2023, 2:56pm GMT
-
Maria Menounos Suspected 'Something's Wrong' Before Pancreatic ... - TODAY
Posted: November 16th, 2023, 2:56pm GMT
-
FDA expert reviews data supporting belzutifan approval for VHL ... - Urology Times
Posted: November 16th, 2023, 1:00pm GMT
-
2023-11-16 | NDAQ:RNXT | Press Release | RenovoRx Inc - Stockhouse Publishing
Posted: November 16th, 2023, 11:42am GMT
2023-11-16 | NDAQ:RNXT | Press Release | RenovoRx Inc Stockhouse Publishing -
RenovoRx Expands Scientific Advisory Board with Appointment of ... - Business Wire
Posted: November 16th, 2023, 11:35am GMT
-
Chemo drug makes Daiichi Sankyo ADC more effective against ... - FierceBiotech
Posted: November 16th, 2023, 10:35am GMT
-
How is ablation therapy used to treat cancer? - MD Anderson Cancer Center
Posted: November 16th, 2023, 6:00am GMT
How is ablation therapy used to treat cancer? MD Anderson Cancer Center -
Lobar Mucus Plugging Reflecting Central Bronchial Tumoral ... - Cureus
Posted: November 16th, 2023, 5:59am GMT
-
Lobar Mucus Plugging Reflecting Central Bronchial Tumoral ... - Cureus
Posted: November 16th, 2023, 5:59am GMT
-
Avelumab for Advanced Merkel Cell Carcinoma | POR - Dove Medical Press
Posted: November 16th, 2023, 11:35pm GMT
Avelumab for Advanced Merkel Cell Carcinoma | POR Dove Medical Press -
SIRPant-M Receives FDA Orphan Drug Designation for T-Cell ... - Targeted Oncology
Posted: November 16th, 2023, 10:04pm GMT
SIRPant-M Receives FDA Orphan Drug Designation for T-Cell ... Targeted Oncology -
Liver Transplantation | NEJM - nejm.org
Posted: November 15th, 2023, 8:02pm GMT
Liver Transplantation | NEJM nejm.org -
Research opens the door to a potential treatment strategy for certain ... - News-Medical.Net
Posted: November 15th, 2023, 7:55pm GMT
-
Dr Li on Frontline Treatment Considerations With IO-Based ... - OncLive
Posted: November 15th, 2023, 7:07pm GMT
-
Targeting DNA methylation and B7-H3 in RB1-deficient and ... - Science
Posted: November 15th, 2023, 5:01pm GMT
-
Novartis and Legend Biotech Sign Exclusive License Agreement for ... - BioPharm International
Posted: November 15th, 2023, 4:58pm GMT
Novartis and Legend Biotech Sign Exclusive License Agreement for ... BioPharm International -
Innovative treatment uses radio frequency to target and reduce ... - Wayne State University
Posted: November 15th, 2023, 1:57pm GMT
Innovative treatment uses radio frequency to target and reduce ... Wayne State University -
GE HealthCare, BAMF Health to build framework for accelerating ... - DOTmed HealthCare Business News
Posted: November 15th, 2023, 12:17pm GMT
GE HealthCare, BAMF Health to build framework for accelerating ... DOTmed HealthCare Business News -
Maria Menounos Says She Predicted Her Pancreatic Cancer Due To Bloating - TODAY
Posted: November 15th, 2023, 6:00am GMT
-
Johnson Analyzes Combination Immunotherapy in the First Line in ... - Targeted Oncology
Posted: November 15th, 2023, 6:00am GMT
Johnson Analyzes Combination Immunotherapy in the First Line in ... Targeted Oncology -
FDA OKs PD-L1 pharmDx for Gastric and GEJ Cancer - Targeted Oncology
Posted: November 14th, 2023, 5:15pm GMT
FDA OKs PD-L1 pharmDx for Gastric and GEJ Cancer Targeted Oncology -
Legend Biotech strikes deal with Novartis to advance small-cell lung ... - BioPharma-Reporter.com
Posted: November 14th, 2023, 10:14am GMT
Legend Biotech strikes deal with Novartis to advance small-cell lung ... BioPharma-Reporter.com -
Twin Cities man's dying wish: Compost me for the benefit of the planet - Star Tribune
Posted: November 13th, 2023, 8:00pm GMT
-
Novartis to Pay Legend Biotech $100M in Pact Bringing Cell ... - MedCity News
Posted: November 13th, 2023, 4:05pm GMT
-
Novartis licenses Legend cell therapy for lung cancer - BioPharma Dive
Posted: November 13th, 2023, 3:15pm GMT
Novartis licenses Legend cell therapy for lung cancer BioPharma Dive -
Carcinoid syndrome: Symptoms, causes, treatments, and more - Medical News Today
Posted: November 13th, 2023, 2:26pm GMT
Carcinoid syndrome: Symptoms, causes, treatments, and more Medical News Today -
Karmanos Cancer Institute first to receive new FDA-approved ... - PR Newswire
Posted: November 13th, 2023, 12:00pm GMT
-
Karmanos Cancer Institute first to receive new FDA-approved ... - McLaren Health Care
Posted: November 13th, 2023, 10:46am GMT
Karmanos Cancer Institute first to receive new FDA-approved ... McLaren Health Care -
Case series of ovarian neuroendocrine carcinoma: overview of ... - BioMed Central
Posted: November 13th, 2023, 1:54am GMT
-
Validea's Top Health Care Stocks Based On Motley Fool - 11/12/2023 - Nasdaq
Posted: November 12th, 2023, 1:00pm GMT